yi-han-dulkeith-stretched-ver
18 August 2022Muireann Bolger

Jones Day hires new counsel for New York IP practice

Jones Day has announced that Yi Han Dulkeith has joined the firm’s IP practice in New York.

Dulkeith, who joins from Baker Botts, counsels research institutions and universities as well as biotechnology and biopharmaceutical companies. She advises clients on their technologies including immunotherapy, gene editing, and cell therapies including stem cell technology and engineered cells, and diagnostics.

Dulkeith began her career in the legal profession as a science advisor, handling patent prosecution matters and opinions, as well as directing and devising strategies in re-examination proceedings before the US Patent and Trademark Office.

“She brings her impressive combination of legal and biotechnology skills and training to advise emerging and world-leading biotech and biopharmaceutical companies,” said Anthony Insogna, practice leader of Jones Day’s IP practice.

“In particular, her experience with strategic portfolio management and prosecution, due diligence and post-grant proceedings will be a tremendous asset to our clients. I am pleased to welcome her to Jones Day.”

"With extensive experience representing non-profit and health-care organisations, research institutes, as well as start-up biotech companies and multinational biopharmaceutical companies, her blend of deep technical knowledge and proven legal skills will be terrific for our clients,” added Leon DeJulius, partner-in-charge of Jones Day’s New York office.

Did you enjoy reading this story?  Sign up to our free daily newsletters and get stories sent like this straight to your inbox.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
11 March 2021   Ferring Pharmaceuticals has asked The District Court for the Southern District of New York to impose sanctions on law firm Jones Day for allegedly forcing its client Serenity Pharmaceuticals into pursuing litigation against Ferring.
article
7 August 2019   Hooper, Lundy and Bookman has appointed Andrew Woodmansee to head up a new IP practice at the firm.

More on this story

Big Pharma
11 March 2021   Ferring Pharmaceuticals has asked The District Court for the Southern District of New York to impose sanctions on law firm Jones Day for allegedly forcing its client Serenity Pharmaceuticals into pursuing litigation against Ferring.
article
7 August 2019   Hooper, Lundy and Bookman has appointed Andrew Woodmansee to head up a new IP practice at the firm.

More on this story

Big Pharma
11 March 2021   Ferring Pharmaceuticals has asked The District Court for the Southern District of New York to impose sanctions on law firm Jones Day for allegedly forcing its client Serenity Pharmaceuticals into pursuing litigation against Ferring.
article
7 August 2019   Hooper, Lundy and Bookman has appointed Andrew Woodmansee to head up a new IP practice at the firm.